Literature DB >> 17717064

A novel role of complement in mobilization: immunodeficient mice are poor granulocyte-colony stimulating factor mobilizers because they lack complement-activating immunoglobulins.

Ryan Reca1, Daniel Cramer, Jun Yan, Mary J Laughlin, Anna Janowska-Wieczorek, Janina Ratajczak, Mariusz Z Ratajczak.   

Abstract

Complement (C) and innate immunity emerge as important and underappreciated modulators of mobilization of hematopoietic stem/progenitor cells (HSPC). We reported that (a) C becomes activated in bone marrow (BM) during granulocyte-colony-stimulating factor (G-CSF)-induced mobilization by the classic immunoglobulin (Ig)-dependent pathway and that (b) C3 cleavage fragments increase the responsiveness of HSPC to a stromal derived factor-1 gradient. Since patients suffering from severe combined immunodeficiency (SCID) mobilize poorly, we hypothesized that this could be directly linked to the lack of C activating Ig in these patients. In the current study to better elucidate the role of C activation in HSPC mobilization, we mobilized mice that lack Ig (RAG2, SCID, and Jh) by G-CSF or zymosan, compounds that activate C by the classic Ig-dependent and the alternative Ig-independent pathways, respectively. In addition, we evaluated mobilization in C5-deficient animals. Mobilization was evaluated by measuring the number of colony-forming unit-granulocyte macrophage and leukocytes circulating in peripheral blood. We found that (a) G-CSF- but not zymosan-induced mobilization was severely reduced in RAG2, SCID, and Jh mice; (b) impaired G-CSF-induced mobilization was restored after infusion of purified wild-type Ig; and (c) mobilization was severely reduced in C5-deficient mice. These data provide strong evidence that the C system plays a pivotal role in mobilization of HSPC and that egress of HSPC from BM occurs as part of an immune response. Disclosure of potential conflicts of interest is found at the end of this article.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17717064     DOI: 10.1634/stemcells.2007-0525

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  31 in total

1.  Complement C1q enhances homing-related responses of hematopoietic stem/progenitor cells.

Authors:  Ali Jalili; Leah Marquez-Curtis; Neeta Shirvaikar; Marcin Wysoczynski; Mariusz Ratajczak; Anna Janowska-Wieczorek
Journal:  Transfusion       Date:  2010-09       Impact factor: 3.157

2.  Poor Mobilization in T-Cell-Deficient Nude Mice Is Explained by Defective Activation of Granulocytes and Monocytes.

Authors:  Marcin Wysoczynski; Mateusz Adamiak; Malwina Suszynska; Ahmed Abdel-Latif; Janina Ratajczak; Mariusz Z Ratajczak
Journal:  Cell Transplant       Date:  2016-07-18       Impact factor: 4.064

3.  Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells.

Authors:  Ayelet Dar; Amir Schajnovitz; Kfir Lapid; Alexander Kalinkovich; Tomer Itkin; Aya Ludin; Wei-Ming Kao; Michela Battista; Melania Tesio; Orit Kollet; Neta Netzer Cohen; Raanan Margalit; Eike C Buss; Francoise Baleux; Shinya Oishi; Nobutaka Fujii; Andre Larochelle; Cynthia E Dunbar; Hal E Broxmeyer; Paul S Frenette; Tsvee Lapidot
Journal:  Leukemia       Date:  2011-04-15       Impact factor: 11.528

Review 4.  A novel perspective on stem cell homing and mobilization: review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients.

Authors:  M Z Ratajczak; C H Kim; A Abdel-Latif; G Schneider; M Kucia; A J Morris; M J Laughlin; J Ratajczak
Journal:  Leukemia       Date:  2011-09-02       Impact factor: 11.528

5.  HIF prolyl hydroxylase inhibitor FG-4497 enhances mouse hematopoietic stem cell mobilization via VEGFR2/KDR.

Authors:  Kavita Bisht; Marion E Brunck; Taichi Matsumoto; Crystal McGirr; Bianca Nowlan; Whitney Fleming; Thomas Keech; Graham Magor; Andrew C Perkins; Julie Davies; Gail Walkinshaw; Lee Flippin; Ingrid G Winkler; Jean-Pierre Levesque
Journal:  Blood Adv       Date:  2019-02-12

6.  The Therapeutic Effects of Human Mesenchymal Stem Cells Primed with Sphingosine-1 Phosphate on Pulmonary Artery Hypertension.

Authors:  Hyunsook Kang; Kang-Hyun Kim; Jisun Lim; You-Sun Kim; Jinbeom Heo; Jongjin Choi; Jaeho Jeong; YongHwan Kim; Seong Who Kim; Yeon-Mok Oh; Myung-Soo Choo; Jaekyoung Son; Su Jung Kim; Hyun Ju Yoo; Wonil Oh; Soo Jin Choi; Sei Won Lee; Dong-Myung Shin
Journal:  Stem Cells Dev       Date:  2015-04-09       Impact factor: 3.272

Review 7.  Cellular players of hematopoietic stem cell mobilization in the bone marrow niche.

Authors:  Joshua Tay; Jean-Pierre Levesque; Ingrid G Winkler
Journal:  Int J Hematol       Date:  2016-12-10       Impact factor: 2.490

Review 8.  The complement cascade as a mediator of tissue growth and regeneration.

Authors:  Martin J Rutkowski; Michael E Sughrue; Ari J Kane; Brian J Ahn; Shanna Fang; Andrew T Parsa
Journal:  Inflamm Res       Date:  2010-06-02       Impact factor: 4.575

9.  Mobilization studies in complement-deficient mice reveal that optimal AMD3100 mobilization of hematopoietic stem cells depends on complement cascade activation by AMD3100-stimulated granulocytes.

Authors:  H M Lee; M Wysoczynski; R Liu; D-M Shin; M Kucia; M Botto; J Ratajczak; M Z Ratajczak
Journal:  Leukemia       Date:  2009-12-24       Impact factor: 11.528

10.  Impaired mobilization of hematopoietic stem/progenitor cells in C5-deficient mice supports the pivotal involvement of innate immunity in this process and reveals novel promobilization effects of granulocytes.

Authors:  H M Lee; W Wu; M Wysoczynski; R Liu; E K Zuba-Surma; M Kucia; J Ratajczak; M Z Ratajczak
Journal:  Leukemia       Date:  2009-08-06       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.